Research Highlights
The clinical trial will last about six to eight months, with participants attending several study visits. During the clinical visits, participants will be placed in one of two groups:
- 1-Dose Group: Two clinic visits and one phone check-in.
- 2-Dose Group: Three clinic visits and one phone check-in.
Some clinic visits will include blood tests to check the immune response. Participation is free, but participants will be compensated for their time and effort.
Eligibility Criteria
To participate, children must be healthy and between 7 months and 17 years old. Other requirements include:
Vaccination History:
- Aged 7 to 23 months: Must not have had any pneumococcal vaccines.
- Aged 2 to 17 years: Can have previous vaccinations but must provide full medical and vaccination records.
- Restrictions: Children aged 6 to 17 years must not have received the PCV20 vaccine.
What to Expect?
Children in this study will receive either the new pneumococcal vaccine (PG4) or an approved vaccine (Prevnar 20®). No one will receive a placebo.
Our research team will closely monitor your child’s health throughout the study. Parents will get detailed information about the possible benefits and risks of participating.
Frequently Asked Questions
What is the pediatric pneumococcal vaccine study about?
Our pediatric pneumococcal vaccine study aims to understand how well the vaccine works compared to an approved treatment and its potential benefits for children’s health. The goal is to provide children with maximum protection against serious illnesses like pneumonia and other pneumococcal diseases.
What are pneumococcal diseases?
Pneumococcal diseases are serious infections caused by the bacteria Streptococcus pneumoniae. They can affect different parts of the body and include illnesses such as pneumonia, meningitis, bacteremia, otitis media, and sinusitis, and can be especially serious in children.
What does participation involve?
The trial lasts about six to eight months, with several study visits. Children are placed in one of two groups: a 1-dose group with two clinic visits and one phone check-in, or a 2-dose group with three clinic visits and one phone check-in. Some visits include blood tests to check the immune response. Participation is free, and participants are compensated for their time and effort.
What are the eligibility criteria?
To participate, children must be healthy and between 7 months and 17 years old. Children aged 7 to 23 months must not have had any pneumococcal vaccines, while those aged 2 to 17 years may have had previous vaccinations but must provide full medical and vaccination records. Children aged 6 to 17 years must not have received the PCV20 vaccine.
What will my child receive in the study?
Children in this study receive either the new pneumococcal vaccine (PG4) or an approved vaccine (Prevnar 20). No one receives a placebo. Our research team closely monitors your child’s health throughout the study, and parents receive detailed information about the possible benefits and risks.
Volunteer Reviews
Google Based Reviews
A’m very grateful about this opportunity the staff are very professional and friendly I recommend AGA Clínica Research because they really help people to improve their lives thanks
~ Gladys Alvarez
I am very happy with the attention first of the doctor who is an excellent doctor, very kind, an excellent human being and the attention of his assistants such as the laboratory assistant..
~ Rosario Casais
Amazing service! The staff is very nice and patient with me and my family. I was seen right away. No wait time. Great experience!
~ Erika
Employees are very professional and friendly. Always able to convey the necessary information to the patient in the most accessible way.
~ Paola Allende
Very detailed and thorough in explaining. The office staff is friendly, warm and attentive.
~ Milerka Lantigua
Excellent service from the staff, the phlebotomist is very experienced and very good. The atmosphere is very pleasant and the coordinators are girls who are very attentive to everyone. The long time doctor is still here.
~ Dignora Ortega
Enroll Today for a Healthier Tomorrow!
If your child qualifies and you’re interested in joining, please contact us for more details. Our experts at AGA Clinical Trials will help you with the enrollment process and answer any questions you may have. Your participation in our pediatric pneumococcal vaccine clinical trials can help create a healthier future for children. Call us at (786) 326-1583 for more information.